Glancy Prongay & Murray LLP Commences Investigation on Behalf of Bruker Corporation Investors (BRKR)

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Bruker Corporation (“Bruker” or the “Company”) (NASDAQ: BRKR) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the Bruker investigation page on our website www.glancylaw.com/case/bruker-corporation.

On October 19, 2017, in a 10-Q filing, Bruker announced that it received a notice of investigation and subpoena to produce documents from the Division of Enforcement of the SEC. The subpoena seeks information related to an employee terminated as part of a restructuring and certain matters involving the company's policies and accounting practices related to revenue recognition and restructuring activities, as well as related financial reporting, disclosure and compliance matters, since January 1, 2013. The subpoena also seeks information concerning, among other things, the company's previously identified material weakness in internal controls over the accounting for income taxes, related financial reporting matters and certain payments for non-employee travel expenses.

On this news, shares of Bruker fell sharply during after hours trading.

Follow us for updates on Twitter: twitter.com/GPM_LLP.

If you purchased Bruker securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067, at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171109006787/en/